Search

Copyright of Namık Kemal Tıp Dergisi is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

OBJECTIVE: We compared the survival outcomes of surgery within multimodality treatment regimens with the outcomes of definitive chemoradiation treatments in patients diagnosed with clinical (c) IIIB/N2 non-small cell lung cancer (NSCLC). We investigated whether surgery within multimodality treatment provides a survival advantage at this stage. MATERIAL AND METHODS: Data from 79 patients with cIIIB/N2 between 2009 and 2016 were analyzed retrospectively. While the surgery was performed after neoadjuvant therapy in 51 cases (IIIB/Surgery Group), definitive chemotherapy ± radiotherapy was applied in 28 cases (IIIB/Definitive Group). RESULTS: In cIIIB/N2 cases, the 5-year overall survival (OS) was 27.4%, with a median OS of 24.6 months. The 5-year OS of the IIIB/ Surgery Group was 27.3% (median survival 22.5 months), while it was 28.6% (median survival 29.1 months) in the IIIB/Definitive Group (P = .387, HR = 0.798, 95% CI, 0.485-1.313). Although there was a survival advantage in the group with a pathological complete response (PCR) after surgery (n = 14) compared to the group that did not (n = 37), the observed difference was not statistically significant. (5-year OS; 42.9% vs. 18.5%, P = .104). Additionally, there was no statistically significant difference between the survival of PCR patients and the IIIB/Definitive Group in terms of OS (P = .488). CONCLUSION: Surgery performed within multimodality treatment regimens in selected cIIIB/N2 cases did not provide a survival advantage over definitive chemoradiation treatments. [ABSTRACT FROM AUTHOR]

Objective Informed consent is the permission obtained verbally and in writing by the physician, so that the patient, who has the power of discrimination and has the ability to evaluate the legal consequences of his/her actions, can make a decision about the procedure and treatment to be applied.This study is a survey study aiming to determine the level of knowledge of Thoracic Diseases and Thoracic Surgery physicians about informed consent. Material and Method The "Informed Consent Knowledge Level Questionnaire" prepared by the researchers was applied to the Thoracic Diseases and Thoracic Surgery physicians working in the hospital between February and May 2020 by face-to-face interview technique. Significance was evaluated at the p<0.05 level. Results The questionnaire was applied to 84 physicians. 69% of the participants were women, 71.4% were thoracic diseases physicians, 28.6% were thoracic surgeons, and the mean age was 36.93±11.58 years. It was determined that 71.4% of the participants received training on informed consent during or after university education, and 97.6% had an informed consent form in their department. 92.9% of the physicians think that having the patient sign an informed consent form will protect them from malpractice lawsuits. While it was determined that the mean level of informed consent knowledge was 70.46±9.09 (min:50-max:85), it was established that there was no statistically significant relationship between status, branch, length of service in medicine and branch, and having been educated about informed consent and the level of informed consent knowledge (p>0.05). Conclusion It has been determined that physicians think that informed consent will protect them from malpractice lawsuits, that the practice of obtaining consent has become widespread, but physicians continue to feel the need to receive education on consent. Although no significant relationship was found between the level of informed consent knowledge and the parameters obtained in the study, the ongoing education needs of physicians on this subject should also be taken into consideration. In order to better understand the factors affecting the level of informed consent knowledge, it is recommended to conduct a large-scale survey classified according to different hospitals, different geographical regions, different age groups and statuses. [ABSTRACT FROM AUTHOR]